Literature DB >> 33667367

A vicious cycle in atherosclerosis.

Aldons J Lusis1.   

Abstract

Clonal hematopoiesis, defined as the presence of expanded somatic blood cell clones, is associated with about a doubling in the risk of coronary heart disease in humans. Heyde and colleagues now provide evidence that clonal hematopoiesis results largely from increased stem cell proliferation, which is, in turn, stimulated by atherosclerosis.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33667367     DOI: 10.1016/j.cell.2021.02.005

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  4 in total

Review 1.  Clonal Hematopoiesis of Indeterminate Potential: an Expanding Genetic Cause of Cardiovascular Disease.

Authors:  Romit Bhattacharya; Alexander G Bick
Journal:  Curr Atheroscler Rep       Date:  2021-09-01       Impact factor: 5.967

2.  Exploring the Potential of Eltrombopag: Room for More?

Authors:  Francesco Tarantini; Cosimo Cumbo; Luisa Anelli; Antonella Zagaria; Maria Rosa Conserva; Immacolata Redavid; Giorgina Specchia; Pellegrino Musto; Francesco Albano
Journal:  Front Pharmacol       Date:  2022-05-23       Impact factor: 5.988

3.  Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link?

Authors:  Cosimo Cumbo; Francesco Tarantini; Antonella Zagaria; Luisa Anelli; Crescenzio Francesco Minervini; Nicoletta Coccaro; Giuseppina Tota; Luciana Impera; Elisa Parciante; Maria Rosa Conserva; Immacolata Redavid; Paola Carluccio; Mario Delia; Annamaria Giordano; Maria Chiara Longo; Tommasina Perrone; Antonella Russo Rossi; Giorgina Specchia; Pellegrino Musto; Francesco Albano
Journal:  Front Oncol       Date:  2022-04-12       Impact factor: 5.738

Review 4.  Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential in Hematology and Cardiovascular Disease.

Authors:  Gregor Hoermann
Journal:  Diagnostics (Basel)       Date:  2022-07-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.